HRT supplementation and prognosis
 

Wow, interesting study. I know of one other small study that indicated that bc relapsed was slightly increased in those taking HRT for three years or more than those not for hormonal positive breast cancer. However, in the hormonal negative bc group, was less increase.

PS. I can see why your own estrogen, phytoestogens and HRT may decrease distant bone mets as bone turn over is decreased with estrogen therapy. The same would hold true for biphosphonates. See supporting article link:

http://www.asco.org/portal/site/ASCO...abstractID=229